Carl Zeiss Meditec AG Logo

Carl Zeiss Meditec AG

ISIN

DE0005313704

Ticker

AFX

Sector

Health Care

Sub-Industry

Health Care Equipment

Country

Germany

Year Founded

1977

About Carl Zeiss Meditec AG

Company Description

Under the umbrella of the MDAX and TecDAX-listed company Carl Zeiss Meditec AG, which is one of the world’s leading medical technology companies, the Medical Technology activities of ZEISS are bundled. Carl Zeiss AG holds ca. 59 percent interest.

The Carl Zeiss Meditec AG has set itself the task to develop innovative products to improve the diagnosis and treatment of diseases. The solutions the Company develops aim to simplify clinical workflows and allow physicians to focus all their attention on their work and their patients. After all, at the end we want the patient to leave the clinic with the best possible outcome and a high level of satisfaction.

Therefor we are guided by our Mission to uniquely enable healthcare professionals worldwide to improve the lives of their patients in ophthalmology, microsurgery and other medical growth sectors and advance the standards of care with our proven medical technology and application competence.

Headcount

3,531

Served Area

Worldwide

Headquarters

Göschwitzer Straße 51-52
7745, Jena
Germany

Filings & Publications

  • Consolidated Report 2022 - Q2 English πŸ‡¬πŸ‡§
  • Consolidated Report 2022 - Q3 English πŸ‡¬πŸ‡§
  • Consolidated Report 2022 - Q4 English πŸ‡¬πŸ‡§
  • Consolidated Report 2020 - Q1 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2020 - Q1 English πŸ‡¬πŸ‡§
  • Consolidated Report 2020 - Q2 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2020 - Q2 English πŸ‡¬πŸ‡§
  • Consolidated Report 2020 - Q3 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2020 - Q3 English πŸ‡¬πŸ‡§
  • Consolidated Report 2020 - Q4 English πŸ‡¬πŸ‡§
  • Consolidated Report 2019 - Q1 English πŸ‡¬πŸ‡§
  • Consolidated Report 2019 - Q1 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2019 - Q2 English πŸ‡¬πŸ‡§
  • Consolidated Report 2019 - Q2 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2019 - Q3 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2019 - Q3 English πŸ‡¬πŸ‡§
  • Consolidated Report 2019 - Q4 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2019 - Q4 English πŸ‡¬πŸ‡§
  • Consolidated Report 2018 - Q1 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2018 - Q1 English πŸ‡¬πŸ‡§
  • Consolidated Report 2018 - Q2 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2018 - Q2 English πŸ‡¬πŸ‡§
  • Consolidated Report 2018 - Q3 English πŸ‡¬πŸ‡§
  • Consolidated Report 2018 - Q3 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2018 - Q4 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2018 - Q4 English πŸ‡¬πŸ‡§
  • Consolidated Report 2017 - Q4 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2017 - Q4 English πŸ‡¬πŸ‡§
  • Consolidated Report 2023 - Q1 English πŸ‡¬πŸ‡§
  • Consolidated Report 2021 - Q1 English πŸ‡¬πŸ‡§
  • Consolidated Report 2021 - Q1 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2021 - Q2 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2021 - Q2 English πŸ‡¬πŸ‡§

Capital Markets Information

ISIN

DE0005313704

LEI

529900GRL4MZ8NMOOK95

Listed Stock Exchange

Frankfurt Stock Exchange

Stock Index

MDAX

TecDAX

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.